Myellama Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Myellama Therapeutics General Information

Description

Developer of immunotherapy biotechnology designed to create targeted treatments for cancers and autoimmune diseases using mRNA delivery and llama-derived antibodies. The company offers a discovery program that identifies malignant and immune cell targets, engineers specific antibodies, applies mRNA technology for delivery, and collaborates with research institutions for pre-clinical development, enabling healthcare providers and patients to access advanced therapeutic options that improve precision, reduce costs, enhance accessibility, and expand long-term management of cancer and autoimmune conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 169 John Street
  • Toronto, Ontario M5T 1X3
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 169 John Street
  • Toronto, Ontario M5T 1X3
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myellama Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-May-2026 Completed Clinical Trials - Phase 1
To view Myellama Therapeutics’s complete valuation and funding history, request access »

Myellama Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
FACIT Venture Capital Minority
To view Myellama Therapeutics’s complete investors history, request access »

Myellama Therapeutics FAQs

  • When was Myellama Therapeutics founded?

    Myellama Therapeutics was founded in 2025.

  • Where is Myellama Therapeutics headquartered?

    Myellama Therapeutics is headquartered in Toronto, Canada.

  • What industry is Myellama Therapeutics in?

    Myellama Therapeutics’s primary industry is Drug Discovery.

  • Is Myellama Therapeutics a private or public company?

    Myellama Therapeutics is a Private company.

  • What is Myellama Therapeutics’s current revenue?

    The current revenue for Myellama Therapeutics is .

  • Who are Myellama Therapeutics’s investors?

    FACIT has invested in Myellama Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process